These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32475214)
1. Associations Between Serum GDF15 Concentrations, Muscle Mass, and Strength Show Sex-Specific Differences in Older Hospital Patients. Herpich C; Franz K; Ost M; Otten L; Coleman V; Klaus S; Müller-Werdan U; Norman K Rejuvenation Res; 2021 Feb; 24(1):14-19. PubMed ID: 32475214 [TBL] [Abstract][Full Text] [Related]
2. Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease. Oba K; Ishikawa J; Tamura Y; Fujita Y; Ito M; Iizuka A; Fujiwara Y; Kodera R; Toba A; Toyoshima K; Chiba Y; Mori S; Tanaka M; Ito H; Harada K; Araki A Geriatr Gerontol Int; 2020 Oct; 20(10):980-987. PubMed ID: 32886834 [TBL] [Abstract][Full Text] [Related]
3. Serum GDF15 Level Is Independent of Sarcopenia in Older Asian Adults. Nga HT; Jang IY; Kim DA; Park SJ; Lee JY; Lee S; Kim JH; Lee E; Park JH; Lee YH; Yi HS; Kim BJ Gerontology; 2021; 67(5):525-531. PubMed ID: 33690236 [TBL] [Abstract][Full Text] [Related]
4. Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study. Alcazar J; Frandsen U; Prokhorova T; Kamper RS; Haddock B; Aagaard P; Suetta C J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1418-1427. PubMed ID: 34617415 [TBL] [Abstract][Full Text] [Related]
5. Different roles of circulating and intramuscular GDF15 as markers of skeletal muscle health. Chiariello A; Conte G; Rossetti L; Trofarello L; Salvioli S; Conte M Front Endocrinol (Lausanne); 2024; 15():1404047. PubMed ID: 38808117 [TBL] [Abstract][Full Text] [Related]
6. Serum Growth Differentiation Factor 15 in Parkinson Disease. Yao X; Wang D; Zhang L; Wang L; Zhao Z; Chen S; Wang X; Yue T; Liu Y Neurodegener Dis; 2017; 17(6):251-260. PubMed ID: 28787735 [TBL] [Abstract][Full Text] [Related]
7. Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls. Tavenier J; Rasmussen LJH; Andersen AL; Houlind MB; Langkilde A; Andersen O; Petersen J; Nehlin JO J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):964-974. PubMed ID: 33428715 [TBL] [Abstract][Full Text] [Related]
8. Annual changes in appendicular skeletal muscle mass and quality in adults over 50 y of age, assessed using bioelectrical impedance analysis. Kołodziej M; Ignasiak Z; Ignasiak T Nutrition; 2021 Oct; 90():111342. PubMed ID: 34166898 [TBL] [Abstract][Full Text] [Related]
9. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes. He X; Su J; Ma X; Lu W; Zhu W; Wang Y; Bao Y; Zhou J Cardiovasc Diabetol; 2020 Mar; 19(1):40. PubMed ID: 32222153 [TBL] [Abstract][Full Text] [Related]
10. Induction of Growth Differentiation Factor 15 in Skeletal Muscle of Old Taurine Transporter Knockout Mouse. Ito T; Nakanishi Y; Yamaji N; Murakami S; Schaffer SW Biol Pharm Bull; 2018; 41(3):435-439. PubMed ID: 29491220 [TBL] [Abstract][Full Text] [Related]
11. Exercise increases circulating GDF15 in humans. Kleinert M; Clemmensen C; Sjøberg KA; Carl CS; Jeppesen JF; Wojtaszewski JFP; Kiens B; Richter EA Mol Metab; 2018 Mar; 9():187-191. PubMed ID: 29398617 [TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease. Koo BK; Um SH; Seo DS; Joo SK; Bae JM; Park JH; Chang MS; Kim JH; Lee J; Jeong WI; Kim W Liver Int; 2018 Apr; 38(4):695-705. PubMed ID: 28898507 [TBL] [Abstract][Full Text] [Related]
13. Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Shin MY; Kim JM; Kang YE; Kim MK; Joung KH; Lee JH; Kim KS; Kim HJ; Ku BJ; Shong M J Korean Med Sci; 2016 Sep; 31(9):1413-8. PubMed ID: 27510384 [TBL] [Abstract][Full Text] [Related]
14. GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness. Conte M; Martucci M; Mosconi G; Chiariello A; Cappuccilli M; Totti V; Santoro A; Franceschi C; Salvioli S Front Immunol; 2020; 11():915. PubMed ID: 32477368 [TBL] [Abstract][Full Text] [Related]
15. Association of circulating calciprotein particle levels with skeletal muscle mass and strength in middle-aged and older adults. Yoshioka M; Kosaki K; Matsui M; Okabe N; Saito C; Yamagata K; Kuro-O M; Maeda S Hypertens Res; 2022 May; 45(5):900-910. PubMed ID: 35241816 [TBL] [Abstract][Full Text] [Related]
16. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study. Fuchs T; Trollor JN; Crawford J; Brown DA; Baune BT; Samaras K; Campbell L; Breit SN; Brodaty H; Sachdev P; Smith E Aging Cell; 2013 Oct; 12(5):882-9. PubMed ID: 23758647 [TBL] [Abstract][Full Text] [Related]
17. Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes. Sabaratnam R; Kristensen JM; Pedersen AJT; Kruse R; Handberg A; Wojtaszewski JFP; Højlund K J Clin Endocrinol Metab; 2024 Jun; 109(7):1754-1764. PubMed ID: 38242693 [TBL] [Abstract][Full Text] [Related]
18. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546 [TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. Visser M; Deeg DJ; Lips P; Harris TB; Bouter LM J Am Geriatr Soc; 2000 Apr; 48(4):381-6. PubMed ID: 10798463 [TBL] [Abstract][Full Text] [Related]
20. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. Visser M; Deeg DJ; Lips P; J Clin Endocrinol Metab; 2003 Dec; 88(12):5766-72. PubMed ID: 14671166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]